Our new prostate profile combines traditional TPSA and FPSA with a novel combination of serum markers. This innovative approach, helps triage patients into “low” and “high-risk” categories, allowing general practitioners to improve patient management in primary care and potentially reduce unnecessary, invasive and costly treatments.

 

Test for:

• Total Prostate Specific Antigen 
• Free Prostate Specific Antigen 
• Interleukin-8 
• Monocyte 
• Chemotactic Protein-1 
• Epidermal Growth Factor 
• Prostate Cancer Risk Score